# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | BCM serum Ca | = | 3.8 | mg 100ml-1 | ALA842766 | mg 100ml-1 | Rattus norvegicus | |||
2. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Ratio | = | 3.4 | ALA846340 | Rattus norvegicus | |||||
3. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | BCM serum Ca | = | 4.1 | mg 100ml-1 | ALA842765 | mg 100ml-1 | Rattus norvegicus | |||
4. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Ratio | = | 3 | ALA846339 | Rattus norvegicus | |||||
5. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Relative potency | = | 1300 | ALA818846 | Homo sapiens | |||||
6. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Relative potency | = | 3 | ALA692641 | Homo sapiens | |||||
7. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Relative potency | = | 0.8 | ALA818871 | Bos taurus | |||||
8. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | BCM serum Ca | = | 4.4 | mg 100ml-1 | ALA842766 | mg 100ml-1 | Rattus norvegicus | |||
9. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Ratio | < | 5.5 | ALA846340 | Rattus norvegicus | |||||
10. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | BCM serum Ca | = | 4.4 | mg 100ml-1 | ALA842765 | mg 100ml-1 | Rattus norvegicus | |||
11. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Ratio | < | 5.5 | ALA846339 | Rattus norvegicus | |||||
12. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Relative potency | < | 0.3 | ALA818846 | Homo sapiens | |||||
13. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Relative potency | = | 190 | ALA692641 | Homo sapiens | |||||
14. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Relative potency | = | 19 | ALA845479 | Rattus norvegicus | |||||
15. | ALA3350860 | 3d (20-epi-beta,beta,alpha) | Relative potency | = | 7 | ALA818871 | Bos taurus |